Nanjing Chia-tai Tianqing Pharmaceutical

This early-stage study is testing an investigational drug called NTB003 for people with moderate-to-severe Thyroid Eye Disease (TED). The main goal is to see if the drug is safe and if it can reduce eye bulging and inflammation. The study will enroll about 74 adults who have had …

This study is testing if adding a new experimental drug called NTQ1062 to a standard hormone therapy (fulvestrant) works better than the standard therapy alone. It is for people with a specific type of advanced breast cancer that has stopped responding to previous hormone treatme…

This study is testing an experimental oral medication called NTQ5082 for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disease. It will compare NTQ5082 against an existing standard treatment to see if it's better at raising and maintaining hemogl…

This study is testing the long-term safety and effectiveness of NTQ5082 capsules for adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare and serious blood disorder. It will follow 78 patients who have already benefited from the treatment in earlier studies. The main goa…